Mingtao Zeng works as an Associate Professor at the Center of Excellence in Infectious Diseases, Paul L. Foster School of Medicine, Tex, USA, and Tech University Health Sciences Center, El Paso, Tex, USA. He received his B.S. degree from Sichuan University, M.S. degree from the Chinese Academy of Sciences, Ph.D. degree in biochemistry from Tel Aviv University, and had postdoctoral training in molecular and cell biology at University of California, Berkeley and in immunology and gene therapy at University of Alabama School of Medicine, Birmingham. Dr. Zeng’s expertise is in vaccine immunology; he has spent the last decade to develop new generation vaccines against respiratory pathogens such as influenza viruses and Streptococcus pneumoniae as well as agents important for biodefense such as bacillus anthracis, botulinum neurotoxins, and francisella tularensis. He is also studying the effect of current vaccination programs on the epidemiological changes of respiratory pathogens (strain replacement and antigenic variation) and how people respond to infections or vaccinations at cellular and molecular levels (T cell, B cell, and gene expression levels). Dr. Zeng has served as a member in numerous grant reviewing committees for National Institute of Health (NIH) and Department of Defense (DOD) in the field of microbial vaccine research. He has been a member of editorial board for several journals and reviewed manuscripts for many journals.
Biography Updated on 28 May 2012